Print this page

Oportunidades de Financiamiento

Marzo 2020

Estimado Investigador:

La Oficina de Investigación del Instituto de Medicina Tropical Alexander von Humboldt pone a su disposición la siguiente información sobre Oportunidades de Financiamiento. 

Por instituciones:



NIH logo 



thrasher research fund


ISID Mainidentifier Yoast



ID Week 2020


unnamed 6


 news logo e1493906223237 800x351














Proyectos de Investigación Aplicada y Desarrollo Tecnológico 2020

Proyectos de Investigación Básica 2020

Movilización en Ciencia, Tecnología e Innovación Tecnológica - Pasantías 2020-01

Movilización en Ciencia, Tecnología e Innovación Tecnológica - Ponencias 2020-02

Organización de Eventos de Ciencia, Tecnología e Innovación Tecnológica 2020-01

Movilización para Investigación en Cambio Climático – AmSud 2020

  • Promover y fortalecer la colaboración y la creación de redes de investigación-desarrollo en el ámbito de la variabilidad climática y el cambio climático, a través de la realización de intercambios entre los equipos participantes (estadías de investigación), para la realización de proyectos colaborativos entre Francia y países de América del Sur: Argentina, Bolivia, Brasil, Chile, Colombia, Ecuador, Paraguay, Perú, Uruguay y Venezuela.
  • Financiamiento:hasta € 20 000
  • Fecha de cierre: 20 de abril
  • Link:

Proyectos de I+D+I con Participación Internacional – CDTI España 2020



  • International Bioethics Research Training Program (D43 Clinical Trial Optional)

    • The overall goal of this initiative is to support the development of a sustainable critical mass of bioethics scholars in low and middle-income country (LMIC) research intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provide research ethics leadership to their institutions, governments and international research organizations. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate didactic, mentored research and training components to prepare multiple individuals with ethics expertise for positions of scholarship and leadership in health research institutions in the LMIC.

    This Funding Opportunity Announcement (FOA) allows support of trainees as the lead investigator of an independent clinical trial; or a separate ancillary study to an existing trial; or to gain research experience in a clinical trial led by another investigator, as part of their research and career development.  

    Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

    • The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.

    This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic, clinical, behavioral and social sciences, community-based, implementation, operations, health services, and health systems research. Cross-disciplinary research as well as HIV associated comorbidities and coinfections affecting the HIV epidemic will be supported under this FOA.

    An application should focus the proposed training program to strengthen research capacity in a defined HIV scientific area at a specific LMIC institution and collaborating LMIC partner institutions.

    This FOA allows qualified Trainees to serve as the lead investigator of an independent clinical trial; or to propose a separate ancillary study to an existing trial under the mentorship of an appropriate clinical researcher or to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

    Learning from the Transfer of HIV Interventions from Low- and Middle-Income Countries (LMICs) to the United States: Informing the Plan for America to End the HIV Epidemic

    • Given potential similarities between low- and middle-income countries (LMICs) and some of the targeted low-resourced settings in this domestic initiative, it is suggested that HIV and related interventions that were originally developed and designed for use in LMICs may be relevant to these high burden areas. Thus, the purpose of this RFI is to identify HIV and other disease interventions developed in LMICs that have been or could be implemented in the U.S. in order to understand the scientific processes by which these interventions have adapted. We are seeking additional information about HIV interventions developed in LMICs that could or should be transferred to the U.S. specifically to address the HIV high burden areas. We would like to understand the role that research, particularly implementation research, can play in the transfer of successful intervention strategies from LMICs to the U.S and how they can be harnessed. We plan to host an NIH workshop to highlight successful and unsuccessful intervention transfers that have been identified through this RFI and other means. Our goal is to harness these lessons learned to develop a scientific research agenda to inform the initiative to end the U.S. HIV epidemic.

    There are many cases of health discoveries made abroad that have been transferred for use in the U.S. For example, in sub-Saharan Africa, emergency management was utilized to establish health service systems to more easily address the HIV epidemic. Once established, the services shifted from emergency to sustainable holistic care programs responsive to community needs, a process that has been replicated in Harlem, New York (REF). Additionally, in the Rio Grande Valley of Texas, scientists are seeking to eliminate the need for multiple follow-up appointments by implementing the use of a high-resolution microendoscope, a low-cost, point-of-care cervical cancer diagnostic tool originally developed for use in Brazil and El Salvador (REF). More examples are listed on page 26 of the FIC Strategic Plan.

    Planning Grant for Global Infectious Disease Research Training Program (D71 - Clinical Trials Not Allowed)

    • This Funding Opportunity Announcement (FOA) encourages applications for a planning grant from institutions in low- and middle-income countries (LMICs) to 1) Design a Global Infectious Disease (GID) Research Training Program in collaboration with U.S. collaborators and 2) Strengthen LMIC faculty and prepare advanced courses and training resources for the program envisioned at the LMIC institution. The application should propose a collaborative process to create a new training program that will strengthen the capacity of the LMIC institution to conduct infectious disease research. Applications should include activities to strengthen LMIC faculty leadership and skills as well as prepare advanced scientific didactic and methodology courses and research training resources development relevant to the program to be planned. A detailed vision for a research training program that focuses on a major endemic or life-threatening emerging infectious disease, neglected tropical disease, infections that frequently occur as a co-infection in HIV infected individuals, or infections associated with non-communicable disease conditions of public health importance in LMICs should be proposed.
    • Letter of intent: September 28, 2020,
    • Application date: October 28, 2020
    • Link:

    Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

    • This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-19-051.

    The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank ( , including “low-income,” “lower-middle-income,” and “upper-middle-income” countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

    • Application due date: November 4, 2020
    • Letter of intent: 30 days before the application due date

    Para más oportunidades de FOGARTY:

NIH logo

  • International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

    • ·The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of high-priority, regionally relevant infectious disease research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Eligibility status of applicant organizations will be determined by this World Bank Classification list at application submission date.
    • Application due date: July 15, 2020;
    • Letter of intent: 30 days prior to the application due date
    • Link:

    Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19 Clinical Trial Not Allowed)

    • This Funding Opportunity Announcement (FOA) solicits applications to establish Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (CARBIRUs) focused on improving our understanding of bacterial and host factors important for antibacterial resistance and infection to inform development of new approaches to prevent, diagnose, and treat antibacterial-resistant infections.
    • Open Date: April 8, 2020
    • Letter of Intent Due Date(s): April 8, 2020
    • Application Due Date(s): May 8, 2020
    • Link:

    Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)

    • The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.  
    • Posted Date: August 7, 2017
    • Expiration Date: September 8, 2020
    • Link:

    Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)

    • The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.
    • ·Open Date (Earliest Submission Date): January 05, 2019
    • ·Expiration Date: January 08, 2022
    • Link:

    Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)

    • The purpose of this Funding Opportunity Announcement is to invite applications for innovative clinical, and preclinical/translational research to develop therapeutic vaccine strategies to improve treatment outcomes of active tuberculosis (TB) in the presence or absence of HIV co-infection.
    • Application Due Date(s):July 28, 2020
    • Link:

    Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)

    • This Funding Opportunity Announcement (FOA) will support basic, translational, and clinical research to improve the understanding of the effector or immunoregulatory potentials of NK cells for HIV prevention, control and/or eradication.
    • Application Due Date(s):July 28, 2020
    • Link:

    Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)

    • The purpose of this Funding Opportunity Announcement is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; with the ultimate goal of advancing the field towards solutions for the improved detection, prevention and treatment of select endemic mycoses.
    • Fecha de cierre: January 08, 2022
    • Link:

    Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)

    • The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immune responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or progression to active tuberculosis (TB) disease. Such responses may be operative in mycobacterial infection, or following vaccination with Bacillus Calmette-Guérin (BCG) or investigational TB vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected and/or uninfected individuals. Research supported under this FOA should go beyond descriptive information currently known about Mtb infection, immune responses to TB vaccines, or immune modulation by non-tuberculous mycobacterial (NTM) infection, or by HIV/AIDS. Applications are sought that include characterization of the timing, anatomical location, and contribution to disease outcome, of mucosal and/or systemic immune responses to mycobacterial infection and/or vaccination. This research is expected to advance understanding of immune mechanisms in Mtb infection/vaccination and contribute to the advancement of new TB vaccines, including in populations also infected with HIV.


Innovator Awards

  • These awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.
  • Financiamiento: Up to £500,000, or up to £750,000 for multidisciplinary collaborations
  • Fecha de cierre: Convocatoria abierta permanentemente
  • Link:

International Training Fellowships

  • Career stage Postgraduate training  Postdoctoral research
  • Where your host organisation is based: Low- or middle-income countries (apart from India and mainland China)
  • Type of researcher:  Basic  ,Clinical,Public health
  • Level of funding: Usually £150,00 to £300,000 for salary, fees and research expenses
  • Duration of funding: 3 years
  • Preliminary application deadline: 30 April 2020
  • Full application deadline: 9 July 2020
  • Link:

International Master’s Fellowships

This scheme offers nationals of low- and middle-income countries the opportunity to receive training at Master’s degree level.

  • Postgraduate training
  • Where your host organisation is based: Low- or middle-income countries
  • Type of researcher:  Basic  ,Clinical,Public health
  • Level of funding: £120,000 including salary, studentship stipend, fees and research expenses
  • Duration of funding: 30 months (12 months taught Master’s course and 18 months research project)
  • Application deadline: 14 April 2020


TDR – Postgraduate training support

Research activities

  • Financian la investigación diseñada para encontrar maneras innovadoras de desarrollar nuevas drogas, las barreras a los insectos y los gusanos que llevan los parásitos, los diagnósticos y otras herramientas contra enfermedades infecciosas en países en vías de desarrollo. Buscan nuevas maneras de distribuir y aumentar el acceso a estas herramientas. El trabajo dirigido por investigadores de países endémicos es siempre una de las principales consideraciones.

thrasher research fund

E.W. "Al" Thrasher Awards

  • The Thrasher Research Fund has been awarding grants for children's medical research for over 40 years. The purpose of the E.W. "Al" Thrasher Awards is to improve children's health through medical research, with an emphasis on​ projects that have the potential to translate into clinically meaningful results within a few years. The Fund awards grants two times per year, with no fixed number of awards given in each funding cycle or in each year.

  • Topics: The Thrasher Research Fund is open to applications that address a variety of significant pediatric problems. Both incidence and severity are considered when determining the significance of the proposed topic. The Fund supports research both within and outside the United States.

Early Career Awards

  • The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Therefore, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The goal is to fund applicants who will go on to be independent investigators. The Fund will make up to 30 awards total with two funding cycles (15 awards each)
  • Concept Submission deadline: March 17, 2020 (Noon Mountain Time)
  • Proposal Submission deadline: May 8, 2020 (Noon Mountain Time)



The ASTMH Annual Meeting draws tropical medicine and global health professionals speaking to the scholarly community, government, non-profits, philanthropy, NGOs, industry, military and private practice. The gathering is intended for specialists, professors, government and general health officials, military faculty, travel clinic physicians, rehearsing physicians in tropical medicine, understudies and all health care suppliers working in the fields of tropical medicine, hygiene and global health.

The Annual Meeting is a five-day instructive gathering that incorporates four pre-meeting courses and draws roughly 4,800 participants.

ASTMH 69th Annual Meeting

  • November 15-19, 2020 (Sunday through Thursday)
  • Metro Toronto Convention Centre, Toronto, Ontario, Canada

Call for Symposia

ISID Mainidentifier Yoast

The International Society for Infectious Diseases (ISID) is collaborating with the Malaysian Society of Infectious Diseases and Chemotherapy (MSIDC) for the 19th International Congress on Infectious Diseases (ICID).

The 19th ICID features an expanded range of sessions by bringing the One Health aspect to the world of clinical infectious diseases and microbiology. The One Health Concept recognizes the commonality of human, environmental and animal health and is critical to understanding, managing and preventing emerging and re-emerging infectious diseases globally. From antimicrobial resistance, Nipah virus and rabies to the effects of climate change, loss of biodiversity, and political instability on infectious diseases, looking through the One Health lens will provide invaluable insights across species and specialties. Connect with colleagues from a wide range of countries and specialties to exchange knowledge, create new ideas and start collaborations.

ID Week 2020

Abstract Guidelines

See information on formatting your abstract, author requirments, the embargo and copyright policy, subject categories, and more. This section is a must see for all those submitting an abstract for IDWeek.

Travel Grants and Awards

The IDWeek Program Committee offers travel grants and awards to support attendance and travel needs of candidates whose abstracts have been selected and who are scheduled to present their work at the IDWeek meeting. These awards must be applied for during the regular online abstract submission process and cannot be applied for after the May 7, 2020, 5 p.m. deadline. See the available awards and requirements.




Health Systems Research Initiative Call 7: Providing evidence to strengthen health systems in low and middle income countries

  • Innovative proposals are sought from across the public health, social and biomedical sciences to the seventh annual call for the Health Systems Research Initiative. Up to £4.7 million is available for funding foundation and full proposals under this call. The Department for International Development (DFID), the Medical Research Council (MRC) and Wellcome jointly fund this call in collaboration with the Economic and Social Research Council (ESRC). All funders are committed to funding world-class research with high potential for impact on policy and practice. Launched in 2013, this programme will generate world-class and cutting-edge research that addresses key questions on strengthening and improving health systems in low- and middle-income countries (LMICs). Following an excellent response to this programme from the research community, funding has now been secured for an annual call under this initiative until 2021
  • Status: Open
  • Closing date: 28 May 2020 16:00 GMT+1
  • Link:



PROJECT: Pew Latin American Fellows

The Pew Latin American Fellows Program was established in 1990. Since then, Pew has helped advance the scientific careers of more than 250 past and present Pew fellows. Former Pew fellows can be found in leadership roles in research institutes throughout Latin America, where they are contributing to a vibrant and successful interdisciplinary scientific community. The 30th class of Pew Latin American fellows will be selected after a competitive review process in April 2020. Ten fellowship awardees will be chosen and a grant will be issued by The Pew Charitable Trusts to their sponsoring institutions in the United States by August 2020.

Eligibility for the 2020 award

For the 2020 application process, applicants must have been awarded a Ph.D. and/or M.D. degree by February 1, 2020 but no earlier than July 10, 2015. Preference will be given to applicants who received their undergraduate and graduate degrees from institutions in Latin America. Applicants may have obtained their undergraduate or graduate degrees from a school outside of Latin America but preferably not in the United States. Applicants may not have started their postdoctoral training in the U.S. prior to January 1, 2019. Applicants will not be considered if they have completed graduate work with a proposed sponsor.



ICGEB PhD and Postdoctoral Fellowships 2020 Call Open

GEB is seeking highly motivated scientists wishing to pursue research studies in a world-class scientific environment. Apply now for the ICGEB Arturo Falaschi PhD and Postdoctoral Fellowships in the Life Sciences.

PhD Fellowships include participation in a competitive research programme, access to state-of-the-art facilities, participation in ICGEB Meetings, Seminars and Journal Clubs and a competitive stipend, plus full coverage of tuition fees and health insurance.

  • Closing date for Applications: 31 March 2020

ICGEB offers competitive Postdoctoral Fellowships to highly motivated scientists wishing to pursue postdoctoral research in a world-class scientific environment. The Fellowships comprise a very competitive package including stipend, health insurance and additional benefits. The most successful fellows will also be eligible, upon completion, to apply for ICGEB Early Career Research Grants to support their own research programmes as young PIs upon return to an ICGEB Member State.

  • Closing dates for Applications: 31 March and 30 September 2020

The ICGEB Alumni body constitutes over 400 PhDs who have graduated through courses validated by the Open University UK, JNU, UCT and others, and who are now pursuing careers in the Life Sciences throughout academia, industry, and Government institutions. Join this vibrant, international group and launch a high-level scientific career.


unnamed 6

About NIHR-MRC Trials Methodology Research Partnership (TMRP)

  • The way clinical trials are designed, conducted, analysed, reported and interpreted should continually be questioned so that they are optimal and responsive for a broad range of stakeholders. As such, the past decade has seen the new field of clinical trials methodology research – research about the way we design, conduct, analyse, report and interpret trials. In this context, the MRC/NIHR Trials Methodology Research Partnership (TMRP) initiated in June 2019 to increase capacity for trials methodology research. This partnership included the following working groups; Stratified Medicine, Health Informatics, Adaptive Designs, Outcomes, Trial Conduct, Health Economics, Statistical Analysis, and Global Health.

The Global Health Working Group aims to ensure that the voice of those working in clinical trials in low and middle-income countries is heard, as it cannot be assumed that the same methods will be important, relevant or acceptable in every context; clinical trials methodology researchers in low resourced settings may both benefit from, and contribute to, ongoing developments in clinical trial methodology research globally.


Convocatoria de Actividades 2020:

  • Becas de honor
  • Contribución económica a la Investigación Científica
  • Revista “Diagnóstico”
  • Premio mejores trabajos de investigación
  • Link:

news logo e1493906223237 800x351

Call for Proposals: In maternal and child health. Towards the elimination of congenital infection in Chagas Disease through better tools for diagnosis and treatment




Postdoctoral research position to study HIV reservoir in infected individuals

A three-year postdoctoral research position is open in the Pasternak/Berkhout group, Laboratory of Experimental Virology, Academic Medical Center of the University of Amsterdam.

We are looking for a highly motivated postdoctoral researcher who is interested in innovative research towards an HIV cure. You need to be able to work in a multidisciplinary team and have affinity/experience with molecular virology and/or immunology. You will participate in a research collaboration that aims to identify the molecular signature of the HIV reservoir in infected individuals treated with antiretroviral therapy. In particular, we are interested in dissection of the biology of active HIV reservoir (HIV-infected cells that transcribe viral RNA), as well as in identification and characterization of cellular markers of the reservoir. Moreover, genetic CRISPR-CAS approaches can also be used to remove HIV integrated genome from cells. The HIV cure research is a collaboration between different research groups within the Amsterdam UMC (location AMC) and UMC Utrecht.

We are looking for postdoctoral research candidates with a PhD in Virology or Immunology, and experience with molecular and cellular techniques.

The maximum gross monthly salary based on a 36-hour work week is €4.481,- (scale 10 CAO UMC). The base salary does not include holiday pay (8%) and a year-end bonus (8.3%).

We offer a contract for 12 months, with the possibility to offer a contract renewal for a maximum period of 2 more years.

For informal enquiries please contact Dr. Alexander Pasternak (Esta dirección de correo electrónico está protegida contra spambots. Usted necesita tener Javascript activado para poder verla.).

  • Closing date: March 20, 2020
  • Apply online at


GVN is now accepting applications for the 7th Annual Short Course in Basic and Translational Virology. The course will be held at the Institute of Human Virology at the University of Maryland School of Medicine and the Johns Hopkins School of Public Health in Baltimore, Maryland, USA, July 20 - July 24, 2020.

The Course consists of a one-week intensive schedule on basic, translational, and clinical aspects of viruses of importance to human health, led by leading virologists from GVN Centers of Excellence. All didactic courses focus on state-of-the-art aspects of research regarding specific viruses. Participants will enjoy hallmarks of the course - including significant time for discussion and interaction with renowned medical virology leaders, as well as opportunities to meet with program officials from the U.S. National Institutes of Health (NIH).